Morgan Stanley Ampio Pharmaceuticals, Inc. Transaction History

Morgan Stanley

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.08 - $21.0 $16,264 - $4.27 Million	-203,312 Reduced 65.64%	106,412 $6,000
Q2 2022 Oct 27, 2022	BUY	$0.16 - $0.47 $34,060 - $100,053	212,880 Added 219.82%	309,724 $52,000
Q2 2022 Aug 15, 2022	BUY	$0.16 - $0.47 $34,060 - $100,053	212,880 Added 219.82%	309,724 $52,000
Q1 2022 Oct 27, 2022	SELL	$0.42 - $0.62 $89,409 - $131,985	-212,880 Reduced 68.73%	96,844 $46,000
Q1 2022 May 13, 2022	SELL	$0.42 - $0.62 $771 - $1,138	-1,837 Reduced 1.86%	96,844 $46,000
Q4 2021 Feb 14, 2022	SELL	$0.56 - $1.71 $25,172 - $76,864	-44,950 Reduced 31.3%	98,681 $55,000
Q3 2021 Nov 15, 2021	BUY	$1.21 - $1.8 $173,793 - $258,535	143,631 New	143,631 $237,000

96.6K

Ticker AMPE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 226,287,008
Description
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an...

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

Stay updated on Morgan Stanley with notifications on news.